Effect of δ-opioid receptor activation on BDNF-TrkB vs. TNF-α in the mouse cortex exposed to prolonged hypoxia

Int J Mol Sci. 2013 Jul 31;14(8):15959-76. doi: 10.3390/ijms140815959.

Abstract

We investigated whether δ-opioid receptor (DOR)-induced neuroprotection involves the brain-derived neurotrophic factor (BDNF) pathway. We studied the effect of DOR activation on the expression of BDNF and other proteins in the cortex of C57BL/6 mice exposed to hypoxia (10% of oxygen) for 1-10 days. The results showed that: (1) 1-day hypoxia had no appreciable effect on BDNF expression, while 3- and 10-day hypoxia progressively decreased BDNF expression, resulting in 37.3% reduction (p < 0.05) after 10-day exposure; (2) DOR activation with UFP-512 (1 mg/kg, i.p., daily) partially reversed the hypoxia-induced reduction of BDNF expression in the 3- or 10-day exposed cortex; (3) DOR activation partially reversed the hypoxia-induced reduction in functional TrkB (140-kDa) and attenuated hypoxia-induced increase in truncated TrkB (90-kDa) in the 3- or 10-day hypoxic cortex; and (4) prolonged hypoxia (10 days) significantly increased TNF-α level and decreased CD11b expression in the cortex, which was completely reversed following DOR activation; and (5) there was no significant change in pCREB and pATF-1 levels in the hypoxic cortex. We conclude that prolonged hypoxia down-regulates BDNF-TrkB signaling leading to an increase in TNF-α in the cortex, while DOR activation up-regulates BDNF-TrkB signaling thereby decreasing TNF-α levels in the hypoxic cortex.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 1 / metabolism
  • Animals
  • Benzimidazoles / pharmacology
  • Brain-Derived Neurotrophic Factor / biosynthesis
  • Brain-Derived Neurotrophic Factor / metabolism*
  • CD11b Antigen / metabolism
  • CREB-Binding Protein / metabolism
  • Cerebellar Cortex / metabolism
  • Cerebral Cortex / metabolism
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Down-Regulation
  • Hypoxia / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microglia / metabolism
  • Neurons / metabolism
  • Oligopeptides / pharmacology
  • Receptor, trkB / metabolism*
  • Receptors, Opioid, delta / agonists
  • Receptors, Opioid, delta / metabolism*
  • Signal Transduction
  • Tumor Necrosis Factor-alpha / metabolism*
  • Up-Regulation

Substances

  • 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (1H-benzimidazol-2-yl)(carboxymethyl)methylamide
  • Activating Transcription Factor 1
  • Atf1 protein, mouse
  • Benzimidazoles
  • Brain-Derived Neurotrophic Factor
  • CD11b Antigen
  • Creb1 protein, mouse
  • Cyclic AMP Response Element-Binding Protein
  • Oligopeptides
  • Receptors, Opioid, delta
  • Tumor Necrosis Factor-alpha
  • CREB-Binding Protein
  • Crebbp protein, mouse
  • Receptor, trkB